Symed Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TIZANIDINE HYDROCHLORIDE USP, with a corresponding US DMF Number 33900.
Remarkably, this DMF maintains an Active status since its submission on July 09, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 09, 2022, and payment made on January 27, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II